NO20012152L - Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav - Google Patents

Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav

Info

Publication number
NO20012152L
NO20012152L NO20012152A NO20012152A NO20012152L NO 20012152 L NO20012152 L NO 20012152L NO 20012152 A NO20012152 A NO 20012152A NO 20012152 A NO20012152 A NO 20012152A NO 20012152 L NO20012152 L NO 20012152L
Authority
NO
Norway
Prior art keywords
cell proliferation
producing
same
inhibiting cell
compositions
Prior art date
Application number
NO20012152A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012152D0 (no
Inventor
Shirin Asina
Kanti Jain
Albert L Rubin
Barry Smith
Kurt Stenzel
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rogosin Inst filed Critical Rogosin Inst
Publication of NO20012152D0 publication Critical patent/NO20012152D0/no
Publication of NO20012152L publication Critical patent/NO20012152L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
NO20012152A 1998-11-09 2001-05-02 Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav NO20012152L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/188,476 US6224912B1 (en) 1996-04-03 1998-11-09 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
PCT/US1999/026413 WO2000027207A1 (fr) 1998-11-09 1999-11-09 Compositions de cellules restreintes capables de croissance rapide qui produisent des matieres supprimant la proliferation et utilisation desdites compositions

Publications (2)

Publication Number Publication Date
NO20012152D0 NO20012152D0 (no) 2001-05-02
NO20012152L true NO20012152L (no) 2001-07-05

Family

ID=22693322

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20012152A NO20012152L (no) 1998-11-09 2001-05-02 Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav
NO20101615A NO20101615L (no) 1998-11-09 2010-11-17 Materiale for hemming av proliferasjon av celler, og fremgangsmate til fremstilling av samme, og anvendelse derav.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20101615A NO20101615L (no) 1998-11-09 2010-11-17 Materiale for hemming av proliferasjon av celler, og fremgangsmate til fremstilling av samme, og anvendelse derav.

Country Status (19)

Country Link
US (4) US6224912B1 (fr)
EP (1) EP1128731B1 (fr)
JP (2) JP4294223B2 (fr)
KR (3) KR20050055797A (fr)
CN (1) CN1325271A (fr)
AT (1) ATE446678T1 (fr)
AU (1) AU769411B2 (fr)
CA (1) CA2334483C (fr)
DE (1) DE69941599D1 (fr)
DK (1) DK1128731T3 (fr)
EG (1) EG24212A (fr)
ES (1) ES2335723T3 (fr)
HK (1) HK1039439A1 (fr)
IL (3) IL139704A0 (fr)
NO (2) NO20012152L (fr)
NZ (1) NZ511220A (fr)
PT (1) PT1128731E (fr)
RU (2) RU2268735C1 (fr)
WO (1) WO2000027207A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1418228B1 (fr) * 1994-01-13 2006-03-15 The Rogosin Institute Cellules sécrétoires macro-encapsulées
USRE39542E1 (en) * 1994-01-13 2007-04-03 The Rogosin Institute Preparation of agarose coated, solid agarose-collagen beads containing secretory cells
US7297331B2 (en) * 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US20050053586A1 (en) * 2003-09-04 2005-03-10 Bryan Conn Entrapped stem cells and uses thereof
US20060121077A1 (en) * 2004-11-11 2006-06-08 Lawrence Gazda Method for treating patients with implants of islets which have been kept in long term, in vitro culture
ATE547004T1 (de) * 2005-09-26 2012-03-15 Rogosin Inst Inc Sekretionszellenhaltige macrobeads, die seakem- gold-agarose enthalten, und ihre verwendungen
EP2063239A4 (fr) 2007-06-08 2013-12-25 Hamamatsu Photonics Kk Module spectroscopique
KR101503079B1 (ko) 2007-06-08 2015-03-16 하마마츠 포토닉스 가부시키가이샤 분광기
WO2008149930A1 (fr) 2007-06-08 2008-12-11 Hamamatsu Photonics K.K. Module spectroscopique
JP4891840B2 (ja) 2007-06-08 2012-03-07 浜松ホトニクス株式会社 分光モジュール
JP4887221B2 (ja) 2007-06-08 2012-02-29 浜松ホトニクス株式会社 分光モジュール
JP4891841B2 (ja) 2007-06-08 2012-03-07 浜松ホトニクス株式会社 分光モジュール
US8049887B2 (en) 2007-06-08 2011-11-01 Hamamatsu Photonics K.K. Spectroscopic module
KR20100049084A (ko) 2007-08-23 2010-05-11 인트렉손 코포레이션 질병 진단을 위한 방법 및 조성물
NZ584848A (en) 2007-09-28 2012-09-28 Intrexon Corp Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
WO2009110110A1 (fr) 2008-03-04 2009-09-11 浜松ホトニクス株式会社 Module de spectroscopie
JP2009300418A (ja) 2008-05-15 2009-12-24 Hamamatsu Photonics Kk 分光モジュール
JP5415060B2 (ja) 2008-05-15 2014-02-12 浜松ホトニクス株式会社 分光モジュール
JP5207938B2 (ja) 2008-05-15 2013-06-12 浜松ホトニクス株式会社 分光モジュール及び分光モジュールの製造方法
JP5205241B2 (ja) 2008-05-15 2013-06-05 浜松ホトニクス株式会社 分光モジュール
JP5512961B2 (ja) 2008-05-15 2014-06-04 浜松ホトニクス株式会社 分光モジュール及びその製造方法
JP5205240B2 (ja) 2008-05-15 2013-06-05 浜松ホトニクス株式会社 分光モジュールの製造方法及び分光モジュール
JP5205238B2 (ja) 2008-05-15 2013-06-05 浜松ホトニクス株式会社 分光モジュール
EP2412800A1 (fr) * 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Organoïde du foie, ses utilisations et son procédé de culture pour l'obtenir
US8572921B2 (en) * 2009-03-27 2013-11-05 Davinci Roofscapes, Llc One piece hip and ridge shingle
EP3524672A3 (fr) * 2010-06-16 2019-12-18 Minerva Biotechnologies Corporation Reprogrammation de cellules cancéreuses
SG187603A1 (en) * 2010-08-12 2013-03-28 Janssen Biotech Inc Treatment of diabetes with pancreatic endocrine precursor cells
KR101874654B1 (ko) * 2010-11-23 2018-07-04 더 로고신 인스티튜트, 인크. 암으로부터 고통받는 대상의 예후 결정에 필요한 정보를 제공하는 방법
US9090866B2 (en) 2012-01-31 2015-07-28 The Rogosin Institute Method for manufacture of macrobeads
US10697972B2 (en) 2016-01-12 2020-06-30 Bioatla, Llc Diagnostics using conditionally active antibodies
AU2017207263B2 (en) 2016-01-12 2021-01-07 Bioatla, Llc Diagnostics using conditionally active antibodies
KR200485213Y1 (ko) 2016-11-02 2017-12-07 고수한 높이 조절이 가능한 조립식평상
KR20200116944A (ko) 2018-02-02 2020-10-13 웨이크 포리스트 유니버시티 헬스 사이언시즈 면역요법 관련 오가노이드 및 그의 제조 및 사용 방법

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865689A (en) 1972-11-09 1975-02-11 Hoffmann La Roche Method of producing carcinoembryonic antigens
US4285930A (en) 1977-12-08 1981-08-25 Likhite Vilas V Antigens comprising immunostimulant adjuvants and their use in immunotherapy
US4391909A (en) 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
US4409331A (en) 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
DE3032931C2 (de) 1980-09-02 1982-07-29 Robert Bürkle GmbH & Co, 7290 Freudenstadt Verfahren und Anordnung zur Herstellung von Mehrschicht-Leiterplatten
SE441009B (sv) 1982-03-08 1985-09-02 Kjell Nilsson Sett att immobilisera levande biomaterial i perlformiga polymerer
US4798786A (en) 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
JPS5933223A (ja) 1982-08-20 1984-02-23 Koken Kk 人の悪性腫瘍細胞増殖抑制剤
CA1196862A (fr) 1983-06-01 1985-11-19 Anthony M.F. Sun Microencapsulement de cellules et de tissus vivants
US4663286A (en) 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
US4680174A (en) 1984-05-24 1987-07-14 Damon Biotech, Inc. Induction of immune response by immunization with encapsulated antigen-producing cells
JPS6118721A (ja) 1984-07-06 1986-01-27 Kyowa Hakko Kogyo Co Ltd 新規抗腫瘍性物質
US4997443A (en) 1985-08-26 1991-03-05 Hana Biologics, Inc. Transplantable artificial tissue and process
US4902295A (en) 1985-08-26 1990-02-20 Hana Biologics, Inc. Transplantable artificial tissue
US5618715A (en) 1985-12-20 1997-04-08 Oncogen Limited Partnership Oncostatin M and novel compositions having anti-neoplastic activity
SE8604684L (sv) 1986-11-03 1988-05-04 Excorim Kommanditbolag Sett att belegga fasta partiklar med en hydrofil gel samt genom settet belagda partiklar
JPS6463395A (en) 1987-05-04 1989-03-09 Oncogen Oncostatin m and novel composition having antitumor activity
JPH0216994A (ja) 1988-07-05 1990-01-19 Nippon Mining Co Ltd 細胞増殖阻害因子及びその製造方法
US5053332A (en) 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
US5227298A (en) 1990-08-17 1993-07-13 The Trustees Of Columbia University In The City Of New York Method for microencapuslation of cells or tissue
US5800829A (en) 1991-04-25 1998-09-01 Brown University Research Foundation Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
DE69221484T2 (de) 1991-04-25 1998-02-19 Univ Brown Res Found Implantierbare, biokompatible immunisolator-trägersubstanz zum abgeben ausgesuchter, therapeutischer produkte
ZA939117B (en) * 1992-12-04 1994-08-05 Susanna Elizabeth Chalmers Pharmaceutical product
ATE218893T1 (de) 1993-08-12 2002-06-15 Neurotech Sa Biokompatible immunoisolatorische kapseln, die genetisch veränderte zellen enthalten
EP1418228B1 (fr) * 1994-01-13 2006-03-15 The Rogosin Institute Cellules sécrétoires macro-encapsulées
JPH10502638A (ja) 1994-07-08 1998-03-10 バクスター、インターナショナル、インコーポレイテッド 癌治療のための、腫瘍細胞を収容した埋込可能な装置
US5888497A (en) * 1996-04-03 1999-03-30 The Rogosin Institute Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
JP3765039B2 (ja) 1996-04-03 2006-04-12 ザ・ロゴシン・インスティテュート 拡散性生物学的産物を生産する細胞を含有する移植可能なアガロース―コラーゲンビーズとその利用法
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment

Also Published As

Publication number Publication date
KR20040075922A (ko) 2004-08-30
EP1128731B1 (fr) 2009-10-28
DK1128731T3 (da) 2010-01-25
US7041504B2 (en) 2006-05-09
US6224912B1 (en) 2001-05-01
ES2335723T3 (es) 2010-03-31
CA2334483A1 (fr) 2000-05-18
PT1128731E (pt) 2010-02-02
US6818230B2 (en) 2004-11-16
ATE446678T1 (de) 2009-11-15
US6808705B2 (en) 2004-10-26
US20020168415A1 (en) 2002-11-14
HK1039439A1 (zh) 2002-04-26
IL139704A (en) 2006-12-31
DE69941599D1 (de) 2009-12-10
NO20101615L (no) 2001-07-05
US20030143281A1 (en) 2003-07-31
RU2236855C2 (ru) 2004-09-27
IL177967A0 (en) 2006-12-31
AU769411B2 (en) 2004-01-29
JP2002529060A (ja) 2002-09-10
EP1128731A1 (fr) 2001-09-05
JP2005343899A (ja) 2005-12-15
AU1472600A (en) 2000-05-29
WO2000027207A1 (fr) 2000-05-18
CN1325271A (zh) 2001-12-05
NO20012152D0 (no) 2001-05-02
WO2000027207A8 (fr) 2000-09-21
EG24212A (en) 2008-10-28
CA2334483C (fr) 2012-01-10
JP4294223B2 (ja) 2009-07-08
IL139704A0 (en) 2002-02-10
IL177967A (en) 2010-12-30
EP1128731A4 (fr) 2003-06-04
RU2268735C1 (ru) 2006-01-27
KR20020013465A (ko) 2002-02-20
RU2004115040A (ru) 2005-10-27
KR20050055797A (ko) 2005-06-13
US20030143739A1 (en) 2003-07-31
NZ511220A (en) 2003-12-19

Similar Documents

Publication Publication Date Title
NO20101615L (no) Materiale for hemming av proliferasjon av celler, og fremgangsmate til fremstilling av samme, og anvendelse derav.
CA2291222A1 (fr) Naphtyridinones utiles pour inhiber la proteine tyrosine kinase et une proliferation cellulaire dependant de kinases de cycle cellulaire
WO1998025598A3 (fr) Procedes et compositions pharmaceutiques inhibant la proliferation de cellules tumorales
WO1998053618A3 (fr) Couche cellulaire amelioree pour reseaux amrc comprenant des cellules a six secteurs
CA2308177A1 (fr) Stent intravasculaire et procede de fabrication
WO1998007830A3 (fr) SEQUENCE GENOMIQUE COMPLETE D'UNE ARCHEOBACTERIE METHANOGENE, $i(METHANOCOCCUS JANNASCHII)
AU7585598A (en) Raf kinase inhibitors
NO975557L (no) Immortalisering og dissimortalisering av celler
GB9003939D0 (en) Sulphatase inhibitors
HUP0002101A3 (en) Fluoroether compositions, process for producing them and methods for inhibiting their degradation
NO994309L (no) Fremgangsmaater for undertrykkelse av tumorvekst med kombinasjoner av isoprenoider og statiner
TR199801954T2 (xx) Eprosartan dihidrat ve �retimi ve form�lasyonu i�in bir proses.
IL142720A0 (en) Water-miscible pharmaceutical compositions of paclitaxel
ZA200001621B (en) Process for the production of heterophasic polymer compositions, and compositions thus obtained.
HUP0002921A3 (en) Cyanoguanidines as cell proliferation inhibitors, process for producing them and pharmaceutical compositions containing them
DE50013841D1 (de) Substratgestützte elektroden-elektrolyt-einheit
DK0880569T4 (da) Kompositioner til behandling af jord, fremgangsmåde til fremstilling deraf og anvendelse deraf
AU1337783A (en) New fibrionoltic enzymes
AU4859399A (en) Compositions and methods for treating papillomavirus-infected cells
IN187760B (fr)
AU2001294636A1 (en) Compositions comprising lignin and methods of making and using the same
DK1518930T3 (da) Fremgangsmåder og præparater til inhibering af neoplatisk cellevækst
ES1016923U (es) Modulo perfeccionado para galerias de servicios.
BR9611482A (pt) Atribuição de frequência em uma rede de telecomunicação celular
AU2003204815A1 (en) Methods and compositions for inhibiting neoplastic cell growth

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application